Epizyme Inc banner
E

Epizyme Inc
F:EPE

Watchlist Manager
Epizyme Inc
F:EPE
Watchlist
Price: 559 EUR 3.33% Market Closed
Market Cap: €92.2B

Wall St Price Targets

EPE Price Targets Summary
Epizyme Inc

There are no price targets for EPE.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Epizyme Inc Competitors:
Price Targets
CIGI
Colliers International Group Inc
21% Upside

Revenue
Forecast

-7% / Year
Past Growth
102% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-7% / Year
Past Growth
102% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 8 years, the compound annual growth rate for Revenue has been -7%. The projected CAGR for the next 1 year is 102%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Operating Income Forecast
is not available for Epizyme Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is EPE's stock price target?
Not Available

EPE does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Epizyme Inc?
Projected CAGR
102%

Over the last 8 years, the compound annual growth rate for Revenue has been -7%. The projected CAGR for the next 1 year is 102%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett